Study and enlightenment on drug communication system in US and EUYU Lian-lian, LIN Lin, TIAN Li-juan2193-2201
Research on the development trend of human papillomavirus vaccine based on patent perspectiveSHA Si-yu, DONG Li, HUANG Zhe2202-2208
Analysis of the patents for the formulation technology of anti-tumor drug paclitaxelCHEN Hao, ZHOU Jing2214-2219
Introduction on the key points of communications during registration of new drugsZHANG Qian, AI Xing, ZHU Li-xia, WANG Li-qing, CHEN Xiao-ming, JIANG Yong-lin, FAN Yi2220-2227
Considerations on the alternative dosing regimens of anti-PD-1 or PD-L1 antibodies for treatment of patients with cancer based on pharmacokineticsLIU Mei-xia, MA Jing-yi, LIU Shu-jie, LIU Shao-dan, HE Rui-rui2228-2233
Analysis of the current clinical trials of the combined vaccines containing componential pertussis in ChinaCHEN Yan, LIU Min, LIU Wen-dong, CUI Can, WANG Hai-xue2234-2238
Consideration on the post approval change evaluation of in vitro dissolution profile for solid oral dosage forms of chemical drugsHU Tao, SHENG Yan, QIAN Jing, LIANG Jin-feng2239-2245
Microdialysis and its applications in transdermal drug delivery formulationsZHU Zi-han, MA Xun, YIN Li-hui, DI Bin2246-2253
Progress in mRNA vaccine delivery systems for tumor gene therapyLI Da-wei, LI Shuo-lei, LIU Zheng-ping, XUE Song, YANG Xue-hua, ZHANG Dai-zhou2254-2263